HETERODIMERE VON GLUTAMINSÄURE

Patent europeic · EP2942065 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2942065
Numer da la dumonda
EP15168948
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
07-11-2007
Publitgà
11-11-2015
Concedì
27-06-2018
La protecziun finescha il pli tard
06-11-2027
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
A61K 51/00 (2006.01)
C07B 59/00 (2006.01)
C07C 275/16 (2006.01)
C07C 275/24 (2006.01)
C07C 275/30 (2006.01)
C07C 311/19 (2006.01)
C07D 213/38 (2006.01)
A61P 35/00 (2006.01)
Prioritad
US 857490 P 08.11.2006
US 878678 P 05.01.2007
Derivà da
EP07844938
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-12-2025

    Midada

    Published in Swissreg on 01.12.2025

  2. 01-12-2024

    Midada

    Published in Swissreg on 01.12.2024

  3. 01-12-2023

    Midada

    Published in Swissreg on 01.12.2023

  4. 01-12-2022

    Midada

    Published in Swissreg on 01.12.2022

  5. 21-08-2018

    Represchentant inscrit

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 21.08.2018

  6. 27-06-2018

    Concedì

    Published in Swissreg on 27.06.2018

Partidas

Possessur

Molecular Insight Pharmaceuticals, Inc.

160 Second Street, Cambridge, MA 02142, US

Represchentant

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventur

Babich, John W.

Cambridge, MA 02142, US

Zimmerman, Craig N.

Topsfield, MA 01983, US

Maresca, Kevin P.

Cambridge, MA 02142, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.